FactaeThe Factual News

Biohaven signs a licensing agreement with SK Biopharma for an epilepsy treatment

Biohaven signed a licensing agreement with SK Biopharma in the field of epilepsy.

Published 4h1 sourceupdated 4h
Lire en français
≈ 18s

The fact

The deal could be worth up to several hundred million dollars.

The partnership aims to develop and commercialize a new treatment.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
États-UnisWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on August 26, 2026
← Back to home
Discover

Read more

All marches →
marches

Bill Gates proposes an AI tax and jobs reserved for humans

4h · 1 sourcemarches

Nvidia exceeds Q3 expectations and raises forecasts despite in-house chip competition

31m · 1 sourcemarches

Meta pays $18 billion to settle legal lawsuits in the United States

1h · 1 sourcemarches

Only five ships pass through Strait of Hormuz on Tuesday

7h · 1 sourcemarches

US GDP growth confirms progress in Q2 2026

7h · 1 sourcemarches

Meta in talks for a settlement with U.S. states

13h · 1 source